BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19155480)

  • 1. Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression.
    Relland LM; Mishra MK; Haribhai D; Edwards B; Ziegelbauer J; Williams CB
    J Immunol; 2009 Feb; 182(3):1341-50. PubMed ID: 19155480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR repertoire and Foxp3 expression define functionally distinct subsets of CD4+ regulatory T cells.
    Kuczma M; Pawlikowska I; Kopij M; Podolsky R; Rempala GA; Kraj P
    J Immunol; 2009 Sep; 183(5):3118-29. PubMed ID: 19648277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist ligands expressed by thymic epithelium enhance positive selection of regulatory T lymphocytes from precursors with a normally diverse TCR repertoire.
    Ribot J; Romagnoli P; van Meerwijk JP
    J Immunol; 2006 Jul; 177(2):1101-7. PubMed ID: 16818767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes.
    Leung MW; Shen S; Lafaille JJ
    J Exp Med; 2009 Sep; 206(10):2121-30. PubMed ID: 19737865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diacylglycerol kinase ΞΆ limits the generation of natural regulatory T cells.
    Schmidt AM; Zou T; Joshi RP; Leichner TM; Pimentel MA; Sommers CL; Kambayashi T
    Sci Signal; 2013 Nov; 6(303):ra101. PubMed ID: 24280042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.
    Gottschalk RA; Corse E; Allison JP
    J Exp Med; 2010 Aug; 207(8):1701-11. PubMed ID: 20660617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
    Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
    J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
    Hsieh CS; Zheng Y; Liang Y; Fontenot JD; Rudensky AY
    Nat Immunol; 2006 Apr; 7(4):401-10. PubMed ID: 16532000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message.
    Nazarov-Stoica C; Surls J; Bona C; Casares S; Brumeanu TD
    J Immunol; 2009 Jan; 182(1):102-10. PubMed ID: 19109140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture.
    Kersh GJ; Engle DL; Williams CB; Allen PM
    J Immunol; 2000 Jun; 164(11):5675-82. PubMed ID: 10820243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of the Src homology region 2 domain-containing phosphatase 1 (SHP-1) causes enrichment of CD4+CD25+ regulatory T cells.
    Carter JD; Calabrese GM; Naganuma M; Lorenz U
    J Immunol; 2005 Jun; 174(11):6627-38. PubMed ID: 15905501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for Dicer in immune regulation.
    Cobb BS; Hertweck A; Smith J; O'Connor E; Graf D; Cook T; Smale ST; Sakaguchi S; Livesey FJ; Fisher AG; Merkenschlager M
    J Exp Med; 2006 Oct; 203(11):2519-27. PubMed ID: 17060477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Foxp3 function and expression in the thymic epithelium.
    Liston A; Farr AG; Chen Z; Benoist C; Mathis D; Manley NR; Rudensky AY
    J Exp Med; 2007 Mar; 204(3):475-80. PubMed ID: 17353370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3 enhancers synergize to maximize regulatory T cell suppressive capacity.
    Zong X; Hao X; Xu B; Crawford JC; Wright S; Li J; Zhang Y; Bai L; He M; Jiang M; Fan Y; Connelly JP; Pruett-Miller SM; Berns H; Janke L; Li C; Feng Y
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34086055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in E-protein activity regulate T reg cell development.
    Gao P; Han X; Zhang Q; Yang Z; Fuss IJ; Myers TG; Gardina PJ; Zhang F; Strober W
    J Exp Med; 2014 Dec; 211(13):2651-68. PubMed ID: 25488982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell receptor affinity in thymic development.
    Moran AE; Hogquist KA
    Immunology; 2012 Apr; 135(4):261-7. PubMed ID: 22182461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery.
    Barnes MJ; Krebs P; Harris N; Eidenschenk C; Gonzalez-Quintial R; Arnold CN; Crozat K; Sovath S; Moresco EM; Theofilopoulos AN; Beutler B; Hoebe K
    PLoS Biol; 2009 Mar; 7(3):e51. PubMed ID: 19260764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of regulatory Foxp3+ T cells in the thymic cortex.
    Liston A; Nutsch KM; Farr AG; Lund JM; Rasmussen JP; Koni PA; Rudensky AY
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11903-8. PubMed ID: 18695219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-step process for thymic regulatory T cell development.
    Lio CW; Hsieh CS
    Immunity; 2008 Jan; 28(1):100-11. PubMed ID: 18199417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.